Vantive partners with IDBS to drive global digital transformation in vital organ therapy
Vantive’s commitment to innovation, powered by Polar, positions the company as a forward-thinking leader in vital organ therapy
2 Dec 2025
IDBS, a Danaher company and leading provider of cloud-based data management software for BioPharma R&D and manufacturing, has announced that Vantive has selected the IDBS Polar platform for enterprise-wide deployment across multiple global sites.
This collaboration marks a key milestone in Vantive’s digital transformation journey. By moving from legacy on-premise systems to a unified, cloud-based ecosystem, Vantive will be better positioned to accelerate innovation and simplify operations across R&D and development.
Polar, a GxP-compliant informatics platform, will serve Vantive’s therapy development lifecycle. By connecting global data and workflows, the Polar platform empowers teams to reduce operational complexity, enhance collaboration and accelerate time-to-market for life-saving therapies.
“Vantive’s adoption of Polar is a testament to their commitment to innovation and patient-centric care,” said Pietro Forgione, General Manager at IDBS.
“Behind every innovation at Vantive is a patient, a family, and a care team we aim to serve,” said Annlea Rumfola, Chief Information Officer at Vantive. “With IDBS, we’re strengthening the digital foundation that enables us to continuously enhance and evolve the therapies we deliver globally.”
The rollout spans multiple Vantive sites across North America, Europe and Asia, ensuring consistent data standards and operational excellence across regions. This global deployment is a cornerstone of Vantive’s strategy to scale innovation and deliver personalized therapies with speed and precision.
“This collaboration reflects the growing demand for intelligent, cloud-based platforms that can transform how organizations operate,” added Manish Manakchand, Commercial Director, IDBS APAC. “We’re proud to support Vantive in their journey to redefine vital organ therapy.”
This partnership sets a new benchmark in digital transformation for the life sciences industry. Vantive’s commitment to innovation, powered by Polar, positions the company as a forward-thinking leader in vital organ therapy, ready to meet the evolving needs of patients and healthcare providers worldwide.
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Links
Tags
Frequently asked questions
Show frequently asked questions
Why did Vantive select the IDBS Polar platform?
Vantive selected IDBS Polar to replace legacy on-premise systems with a unified, cloud-based ecosystem. The platform will help simplify R&D and development operations, connect global data and workflows, improve collaboration, reduce operational complexity and accelerate innovation in vital organ therapies.
How will IDBS Polar support Vantive’s therapy development lifecycle?
The GxP-compliant informatics platform will establish consistent data standards across Vantive’s global sites. By connecting teams, workflows and data, Polar is expected to support operational excellence and accelerate time-to-market for personalized, life-saving therapies.
Where will Vantive deploy the IDBS Polar cloud platform?
Vantive will deploy IDBS Polar enterprise-wide across multiple sites in North America, Europe and Asia. The global rollout is a cornerstone of Vantive’s digital transformation strategy, strengthening its digital foundation and enabling therapies to be delivered worldwide with greater speed and precision.
